Planning Grants for Pivotal Clinical Trials in Hemoglobinopathies (R34)

The summary for the Planning Grants for Pivotal Clinical Trials in Hemoglobinopathies (R34) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Planning Grants for Pivotal Clinical Trials in Hemoglobinopathies (R34): Purpose. This FOA issued by the National Heart, Lung, and Blood Institute, National Institutes of Health, solicits Clinical Trial Planning Grant (R34) applications from institutions/organizations that propose to support the development of studies that will answer research questions essential for the design of robust clinical trials, in particular, Phase II and/or III clinical trials in the major hemoglobinopathies, sickle cell disease (SCD), and the thalassemias. Mechanism of Support. This FOA will utilize the Clinical Trial Planning Grant (R34) mechanism. Funds Available and Anticipated Number of Awards. NHLBI intends to commit up to $4.65 million (total cost) over three years. The NHLBI anticipates that it will award up to $1.55 million in FY 2011 to fund six applications in response to this FOA. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.
Federal Grant Title: Planning Grants for Pivotal Clinical Trials in Hemoglobinopathies (R34)
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-HL-11-009
Type of Funding: Grant
CFDA Numbers: 93.839
CFDA Descriptions: Blood Diseases and Resources Research
Current Application Deadline: Sep 14, 2010
Original Application Deadline: Sep 14, 2010
Posted Date: Apr 08, 2010
Creation Date: Apr 08, 2010
Archive Date: Oct 15, 2010
Total Program Funding:
Maximum Federal Grant Award: $450,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants
BLOODSAFE: Research to enhance availability of safe blood for patients with severe anemia ...
BLOODSAFE: Research to enhance availability of safe blood for patients with severe anemia ...
Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowe...
Career Pathway to Independence in Blood Science Award for Physician Scientists (K99/R00 In...
Career Pathway to Independence in Blood Science Award for Physician Scientists (K99/R00 In...
Improved Therapy for Hemophilia and Hereditary Bleeding Disorders
Clinical Hematology Research Career Development Program (K12)
Molecular Mechanisms Underlying Diamond-Blackfan Anemia and Other Congenital Bone Marrow F...
More Grants from the National Institutes of Health
Accelerating Discovery of Efficacious Pre-erythrocytic Stage Malaria Vaccines (U01 Clinica...
Understanding Phage Biology to Support the Development of Bacteriophage Therapy (R21 Clini...
Strategies to Improve Health Outcomes and to Reduce Disparities in Rural Populations (R01 ...
Sustained Release of Antivirals for Treatment or Prevention of HIV (SRATP) (R01 Clinical T...
Organotypic Culture Models developed from Experimental Animals for Chemical Toxicity Scree...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2019 FederalGrants.com